![KGK Science, Nova Mentis Cleared for Psilocybin Clinical Trial to Treat Fragile X Syndrome | Inside Precision Medicine KGK Science, Nova Mentis Cleared for Psilocybin Clinical Trial to Treat Fragile X Syndrome | Inside Precision Medicine](https://www.insideprecisionmedicine.com/wp-content/uploads/2023/02/Psilocybin-1226545326.jpg)
KGK Science, Nova Mentis Cleared for Psilocybin Clinical Trial to Treat Fragile X Syndrome | Inside Precision Medicine
![Nova Mentis, UCF Partner to Develop Saliva Test for Serotonin for ASD | New Serotonin Assay Could Help Diagnose Fragile X | Fragile X News Today Nova Mentis, UCF Partner to Develop Saliva Test for Serotonin for ASD | New Serotonin Assay Could Help Diagnose Fragile X | Fragile X News Today](https://fragilexnewstoday.com/wp-content/uploads/2021/12/Handshake2.png)
Nova Mentis, UCF Partner to Develop Saliva Test for Serotonin for ASD | New Serotonin Assay Could Help Diagnose Fragile X | Fragile X News Today
![Nova Mentis (CSE:NOVA) signs research contract with KGK Science for Phase II A clinical trial | The Market Herald Canada Nova Mentis (CSE:NOVA) signs research contract with KGK Science for Phase II A clinical trial | The Market Herald Canada](https://themarketherald.ca/wp-content/uploads/2022/06/24211-Nova-Mentis-Life-Science-1280x720-e1676388833113.jpg)